U.S. market Closed. Opens in 3 hours 42 minutes

LIPO | Lipella Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue449.62K184.16K259.35K961.68K694.75K
Cost of Revenue1.69K2.55M1.46M975.96K682.89K
Gross Profit447.93K-2.36M-1.20M-14.28K11.86K
Operating Expenses5.19M2.77M2.18M1.02M748.54K
Selling, General & Admin2.16M226.19K718.38K42.59K65.65K
Research & Development3.04M2.55M1.46M975.96K682.89K
Other Operating Expenses-3.04M-45.0057.09KN/AN/A
Operating Income-4.75M-2.59M-1.92M-56.86K-53.79K
Other Expenses / Income126.98K-7.98K50.35K-4.79K-8.06K
Before Tax Income-4.62M-2.60M-1.87M-61.66K-61.85K
Income Tax Expenses5.00-1.63K6.73K4.79K-53.79K
Net Income-4.62M-2.60M-1.87M-66.45K-61.85K
Interest Expenses10.85K9.61K6.83K7.96K8.39K
Basic Shares Outstanding6.00M5.74M5.74M5.69M5.69M
Diluted Shares Outstanding6.00M5.74M5.74M5.69M5.69M
EBITDA-4.74M-2.59M-1.86M-53.69K-53.79K
EBITDA Margin-1,055.18%-1,405.37%-716.66%-5.58%-7.74%
EBIT-4.61M-2.59M-1.86M-53.69K-107.25K
EBIT Margin-1,024.90%-1,405.37%-716.66%-5.58%-15.44%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙